drugset / Trial / NCT00368719

Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

NCT00368719 ↗

RandomizedSingle-groupSingle-blindTreatment

Summary

To assess the long-term safety of tacrolimus ointment

Timeline

Start
2007-09
Primary completion
—
Completion
2016-07

Outcome

Outcome not reported

Stopped: “withdrawn due to contractual issues”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule 0.03 % —
Comparator Tacrolimus Small molecule 0.1 % —

Indications